Agriculture & Agritech Global On demand · 24-48h

Global Magnetic Immunosolid Phase Extractor Market Strategic Research Report

Global Magnetic Immunosolid Phase Extractor Market Strategic…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Magnetic Immunosolid Phase Extractor Market
$2162025
7.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Automatic, Fully Automatic

By Application: Environmental Testing, Food Safety, Biomedicine, Scientific Research, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Roche, Miltenyi Biotec, BIOEASY, TJUMS, BEAVER, LNI, Enriching Biotechnology, ADM Technology, Agile Bio, PreeKem, Thermo Fisher Scientific, PerkinElmer

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 112 pages
Market size 2025
$216
Million USD
Forecast CAGR
7.6%
2025-2032
Forecast 2032
$360.7
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Magnetic Immunosolid Phase Extractor market size is predicted to grow from US$ 216 million in 2025 to US$ 356 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032.

In 2025, the global production of magnetic immunosolid phase extractors reached 4,829 units, with an average selling price of $45,700 per unit. The global annual production capacity for magnetic immunosolid phase extractors is approximately 8,000 units, with a gross margin of about 27.4%. A magnetic immunosolid phase extractor is an instrument or system used for sample pretreatment. It combines the advantages of immunoaffinity (specific binding between antibodies and antigens) and magnetic solid-phase materials, achieving selective enrichment of target substances and removal of impurities through magnetic separation. The core principle is as follows: magnetic particles with specific binding capabilities (mostly magnetic microspheres or magnetic resins surface-modified with antibodies/ligands) are added to the sample, allowing target molecules to selectively bind to the magnetic particles, which are then separated via a magnetic field to accomplish enrichment, washing, and elution for detection. The upstream industry chain of magnetic immunosolid phase extractors includes immunomagnetic beads, magnetic materials, and electromagnetic/permanent magnet separation modules; the midstream consists of magnetic immunosolid phase extractor manufacturers; and the downstream is primarily the environmental testing, food safety, and biomedical industries.

At present, the market for magnetic immunosolid phase extractors is in a phase of rapid growth, driven by the increasing demands for sample pretreatment efficiency and selectivity in fields such as biomedicine, food safety, and environmental monitoring. These instruments, with their advantages of high specificity, operational convenience, and ease of automation, are gradually becoming key tools for the enrichment and purification of trace targets in complex matrices. Synergistic effects along the industry chain are becoming increasingly evident, with continuous breakthroughs in the performance of upstream immunomagnetic beads and magnetic materials, ongoing innovations by midstream manufacturers in magnetic field control, temperature-controlled incubation, and automated workflow integration, while downstream end-users place higher expectations on throughput flexibility, method development convenience, and result reproducibility. At the same time, with the growing demand for precision testing and rapid response, the penetration rate of this instrument in clinical diagnostics, drug residue testing, and pollutant monitoring scenarios has been steadily increasing. However, industry development still faces constraints such as reliance on imported core materials, insufficient method standardization, and end-user concerns regarding equipment costs and operational training. Overall, the market for magnetic immunosolid phase extractors is moving toward miniaturization, intelligence, and multi-scenario adaptability, with the competitive focus gradually extending from hardware performance to comprehensive solutions and full-process service capabilities.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Magnetic Immunosolid Phase Extractor market?

What factors are driving Magnetic Immunosolid Phase Extractor market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Magnetic Immunosolid Phase Extractor market opportunities vary by end market size?

How does Magnetic Immunosolid Phase Extractor break out by Type, by Application?

This report presents a comprehensive overview of the global Magnetic Immunosolid Phase Extractor market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Automatic
  • Fully Automatic

Segment by Number of Channels

  • Single Channel
  • Multi-channel

Segment by Sample Volume

  • <1 mL
  • 1–10 mL
  • 10–100 mL
  • >100 mL

Segment by Application

  • Environmental Testing
  • Food Safety
  • Biomedicine
  • Scientific Research
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Magnetic Immunosolid Phase Extractor market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Environmental Testing, Food Safety, Biomedicine evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Magnetic Immunosolid Phase Extractor Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$216
2025
Forecast
$360.7
2032
CAGR
7.6%
2025–2032
영역들
5
global
Key companies
RocheMiltenyi BiotecBIOEASYTJUMSBEAVERLNIEnriching BiotechnologyADM Technology
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
AutomaticFully Automatic
By Application
Environmental TestingFood SafetyBiomedicineScientific ResearchOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Automatic
  • 3.1.3 Fully Automatic
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Environmental Testing
  • 4.1.3 Food Safety
  • 4.1.4 Biomedicine
  • 4.1.5 Scientific Research
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Roche
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Miltenyi Biotec
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 BIOEASY
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 TJUMS
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 BEAVER
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 LNI
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Enriching Biotechnology
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 ADM Technology
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Agile Bio
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 PreeKem
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Thermo Fisher Scientific
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 PerkinElmer
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Magnetic Immunosolid Phase Extractor market size?
The global Magnetic Immunosolid Phase Extractor market is estimated at US$ 216 million in 2025 (base year) and is projected to reach US$ 356 million by 2032.
What growth rate is expected for the Magnetic Immunosolid Phase Extractor market through 2032?
The market is expected to grow at a CAGR of 7.6% from 2026 to 2032, expanding from US$ 216 million in 2025 to US$ 356 million in 2032, roughly 1.6 times its base-year value.
How is Magnetic Immunosolid Phase Extractor defined?
In 2025, the global production of magnetic immunosolid phase extractors reached 4,829 units, with an average selling price of $45,700 per unit. The global annual production capacity for magnetic immunosolid phase extractors is approximately 8,000 units, with a gross margin of about 27.4%. A magnetic immunosolid phase extractor is an instrument or system used for sample pretreatment.
What are the main segments of the Magnetic Immunosolid Phase Extractor market by type?
By type, the market is segmented into Automatic and Fully Automatic.
Which applications drive demand in the Magnetic Immunosolid Phase Extractor market?
Key applications covered include Environmental Testing, Food Safety, Biomedicine, Scientific Research and Others.
Who are the key players in the Magnetic Immunosolid Phase Extractor market?
Key players profiled include Roche, Miltenyi Biotec, BIOEASY, TJUMS, BEAVER, LNI, Enriching Biotechnology and ADM Technology, among 12 companies covered in total.
Which regions and countries are covered for Magnetic Immunosolid Phase Extractor?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Magnetic Immunosolid Phase Extractor market?
At present, the market for magnetic immunosolid phase extractors is in a phase of rapid growth, driven by the increasing demands for sample pretreatment efficiency and selectivity in fields such as biomedicine, food safety, and environmental monitoring.
What challenges does the Magnetic Immunosolid Phase Extractor market face?
However, industry development still faces constraints such as reliance on imported core materials, insufficient method standardization, and end-user concerns regarding equipment costs and operational training.
Who should buy the Magnetic Immunosolid Phase Extractor market report?
The report is intended for manufacturers and solution providers, distributors and end users in Environmental Testing, Food Safety and Biomedicine, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Magnetic Immunosolid Phase Extractor market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.